Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

945 studies match

clinicaltrialsPublishedShowing 151–200 of 945 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04729387	Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected	terminated	Phase 3	358	Novartis PharmaceuticalsINDUSTRY	26	Jun 4, 2026	clinicaltrials
NCT02972840	A Study of BR Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated MCL	active not recruiting	Phase 3	635	Acerta Pharma BVINDUSTRY	27	Jun 1, 2026	clinicaltrials